NCT04434131View on ClinicalTrials.gov

Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

March 12, 2021

Conditions
COVID-19
Interventions
DRUG

Convalescent Plasma

Study subjects will receive 1 unit (200mL) of SARS-CoV-2 convalescent plasma collected from a single donor who recovered from COVID-19.

Trial Locations (1)

87131

University of New Mexico Health Sciences Center, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT04434131 - Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 | Biotech Hunter | Biotech Hunter